Nagi News - Follow Us!

Nagi Bioscience is proud to announce the closing of a CHF 1.8M Seed financing round

Nagi Bioscience is proud to announce the closing of a CHF 1.8M Seed financing round

Nagi Bioscience raises CHF 1.8 Million to accelerate its mission of setting a new standard for testing safety and efficacy of drugs and chemicals LAUSANNE, Switzerland – December 20, 2019 – Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closingRead more about Nagi Bioscience is proud to announce the closing of a CHF 1.8M Seed financing round[…]